Walden Biosciences

Walden Biosciences

Latest funding
$51,000,000
Venture capital (Series A) - 2020
ARCH Venture Partners UCB Ventures
Team Size
1–10
Employees
$51,000,000 Venture capital (Series A)
WSJ Venture Capital

Walden Biosciences to Fight Kidney Disease With $51 Million Series A